119 related articles for article (PubMed ID: 7147357)
1. Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
Ferrazzi E; Pappagallo GL; Segati R; Vinante O; Galligioni E; Zagonel V; Salvagno L; Fiorentino MV
Tumori; 1982 Aug; 68(4):321-4. PubMed ID: 7147357
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of vindesine in hematological malignancies].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
[TBL] [Abstract][Full Text] [Related]
3. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
[TBL] [Abstract][Full Text] [Related]
4. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
5. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
[TBL] [Abstract][Full Text] [Related]
6. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of vindesine in patients with advanced breast cancer.
Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
[TBL] [Abstract][Full Text] [Related]
8. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
[TBL] [Abstract][Full Text] [Related]
9. A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors.
Bajorin D; Kelsen DP
Cancer Invest; 1990; 8(2):135-41. PubMed ID: 1698110
[TBL] [Abstract][Full Text] [Related]
10. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
[TBL] [Abstract][Full Text] [Related]
11. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
[TBL] [Abstract][Full Text] [Related]
12. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
[TBL] [Abstract][Full Text] [Related]
13. Vindesine in bronchogenic carcinoma: a phase II trial.
Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
[TBL] [Abstract][Full Text] [Related]
14. Initial clinical studies of vindesine.
Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
[TBL] [Abstract][Full Text] [Related]
15. Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.
DiBella NJ; Berris R; Garfield D; Fink K; Speer J; Sakamoto A
Invest New Drugs; 1984; 2(3):323-8. PubMed ID: 6511238
[TBL] [Abstract][Full Text] [Related]
16. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
[TBL] [Abstract][Full Text] [Related]
17. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of vindesine in patients with acute leukemia.
Sklaroff RB; Arlin Z; Young CW
Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
[TBL] [Abstract][Full Text] [Related]
19. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
Miller TP; Jones SE; Chester A
Cancer Treat Rep; 1980; 64(8-9):1001-3. PubMed ID: 7448818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]